Clinical Trial 43607

Skokie, IL 60076


Summary:

The purpose of this study is to compare the effectiveness, safety, and tolerability of upadacitinib to placebo (fake drug without any active substance) on reduction of signs
and symptoms for subjects with axial spondyloarthritis


Qualified Participants Must:

• Be 18 years of age or older
• Be diagnosed with (ankylosing spondylitis [AS] or non-radiographic axial spondyloarthritis [nr-axSpA])
• Have not responded sufficiently to at least 2 NSAIDs or cannot take NSAIDs due to side effects and/or who have been treated with a biologic therapy (for example, adalimumab, etanercept, infliximab, tocilizumab, abatacept, secukinumab, ixekizumab)


Qualified Participants May Receive:

Study-related medication, care, and labs at no cost

Compensation for time and travel for each completed study visit


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.